InvestorsObserver
×
News Home

Should You Accumulate Aileron Therapeutics Inc (ALRN) in Biotechnology Industry?

Thursday, January 12, 2023 02:10 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Aileron Therapeutics Inc (ALRN) in Biotechnology Industry?

The 65 rating InvestorsObserver gives to Aileron Therapeutics Inc (ALRN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 75 percent of stocks in the Biotechnology industry, ALRN’s 65 overall rating means the stock scores better than 65 percent of all stocks.

Overall Score - 65
ALRN has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ALRN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aileron Therapeutics Inc Stock Today?

Aileron Therapeutics Inc (ALRN) stock is trading at $2.89 as of 1:01 PM on Thursday, Jan 12, a rise of $0.16, or 5.92% from the previous closing price of $2.73. The stock has traded between $2.77 and $2.91 so far today. Volume today is low. So far 20,572 shares have traded compared to average volume of 37,173 shares. Click Here to get the full Stock Report for Aileron Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App